Cancer Patients
Conditions
Keywords
Chemotherapy, Virtually Reality, Anxiety, Nursing
Brief summary
This study was conducted as a non-randomized control group experimental study to determine the effect of virtual reality glasses on vital signs and state anxiety levels.
Detailed description
Purpose This study was conducted as a non-randomized control group experimental study to determine the effect of virtual reality glasses on vital signs and state anxiety levels in cancer patients receiving chemotherapy for the first time. Methods and Sample The population of the study was composed of adult patients admitted to an oncology hospital in Ankara province with a diagnosis of stage I-II-III cancer to undergo chemotherapy treatment for the first time. The sample of the study consisted of 30 patients who were assigned to the intervention and control groups by the stratified sampling method (considering such characteristics as age, gender, marital status). The patient identification form, Spielberger state anxiety scale, patient opinion form, vital signs follow-up form, and virtual reality glasses were used to collect the data.
Interventions
DEVICEVirtual Glasses
In the research, Samsung Gear VR SM-R323 brand and model SG glasses provided by the researcher were used. Patients were offered four different options to watch as Forest of Serenity, Calm Place, Happy Place, Gala 360 Travel & Relax. Forest of Serenity is a nature video consisting of bird sounds, colorful trees and flowers, and a clear lake where fish can be seen swimming in it. Calm Place is a relaxing video where cycles are shown 24 hours a day, where a person finds himself by the lake in the forest in snowy, rainy sunny weather. In Happy Place, one finds himself in a virtual camp environment where natural events such as dynamically changing weather, day-night cycles, and falling stars are experienced. Gala 360 Travel & Relax is a Paris-Notre Dame museum tour video.
Sponsors
Bahar İNKAYA
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)
Intervention model description
Semi-experimental
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosed with stage 1,2,3 cancer * Receive radiotherapy and chemotherapy for the first time * Volunteer patients who agreed to participate
Exclusion criteria
-Patients outside the inclusion criteria
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vital signs- Blood pressure | first measurement just before the start of the chemotherapy infusion | Systolic blood pressure values |
| Vital signs-pulse | first measurement just before the start of the chemotherapy infusion | Pulse values |
Countries
Turkey (Türkiye)
Outcome results
None listed